Esthetic Outcomes of Immediately Placed Implants Receiving Immediate Provisionalization and Delayed Restoration
NCT ID: NCT01925339
Last Updated: 2019-02-18
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2015-12-31
2018-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Implants Placed Immediately or Delayed Into Extraction Sites
NCT00067392
The Effect of Immediate Implant Placement and Provisionalization in the Esthetic Zone
NCT02021331
Esthetic, Clinical and Radiographic Outcomes of Immediately Placed Implants (Type 1) and Early Placed Implants (Type 2)
NCT01623739
Immediate vs Delayed Loading of Two Implants Supporting a Mandibular Over Denture
NCT01949298
Effect of Placing the Implant Crown on the Implant on the Same Day as the Implant vs. 4 Weeks Later.
NCT04319042
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The enrolled patients will be randomly placed into one of two treatment groups, immediate implant placement (IIP) and restoration group (IR) or the IIP + delayed restoration group (DR). For all patients, the hopeless tooth will be extracted atraumatically and an implant placed immediately. The decision will be made randomly to either restoring the implant immediately (Test group) with a provisional crown or restoring the implant at 4 months after implant placement (Control group). Outcome analyses will be performed until approximately 1-year after the implant surgery and primarily evaluate clinical and radiographic parameters to determine the esthetic outcomes of immediately restored IIP implants, in comparison to those immediately placed but restored in a delayed approach.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test (immediate restoration)
Test (immediate restoration): immediate restoration will be placed on immediately placed implants.
Test (immediate restoration)
Test (immediate restoration)
Control: delayed restoration
Control: delayed restoration: immediate placed implants will be restored at 4 months.
Control: delayed restoration
Control: delayed restoration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Test (immediate restoration)
Test (immediate restoration)
Control: delayed restoration
Control: delayed restoration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A minimum dentition of 20 permanent teeth (including natural rooted teeth or dental implants; pontic of a fixed bridge is not considered a tooth)
* A maxillary premolar, canine, lateral incisor or central incisor with a hopeless prognosis
* Presence of adjacent teeth and enough clearance for an implant crown
* Presence of sufficient bone apical to the root apex of the hopeless tooth
Exclusion Criteria
* Current heavy smokers (\>10 cigarettes per day) or heavy smokers who quitted less than 1 year
* Pregnant or plan to get pregnant or lactating mothers
* Diseases of the immune system or any medical condition that may influence the outcome (uncontrolled diabetes (HbA1c \>7), neurologic or psychiatric disorders, systemic infections, …)
* Radiation therapy in the head and neck area within 3 years
* Current use of oral bisphosphonates for \>3 years
* History of IV bisphosphonates use
* Other medical conditions that may contradict an implant surgery
Intraoral criteria:
* Area of study is adjacent to an existing implant
* Acute infection at/or adjacent to the extraction site (e.g., sinus tract, swelling, etc.)
* Observable gingival changes due to use of medications such as calcium antagonists, anticonvulsives, immunosuppressives, anti-inflammatory medications, etc.)
* Untreated deep carious lesions or defective restorations that can potentially exacerbate during the course of the experiment
* Uncontrolled periodontal disease
* Poor oral hygiene (\>20% FMPS)
CBCT criteria:
• More than 4 mm of buccal plate dehiscence is present on CBCT scans
Intraoperative criteria:
• More than 4 mm of buccal plate dehiscence is present once the tooth is extracted
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hom-Lay Wang, DDS, MSD, Ph D
Collegiate Professor of Periodontics and Professor of Dentistry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hom-Lay Wang, DDS, MSD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan School of Dentistry
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00070747
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.